Bao, Haiyan
Gao, Juehua
Chen, Yi-Hua
Altman, Jessica K.
Frankfurt, Olga
Wilson, Amanda L.
Sukhanova, Madina
Chen, Qing
Lu, Xinyan
Article History
Received: 19 December 2018
Accepted: 18 March 2019
First Online: 28 March 2019
Ethics approval and consent to participate
: This study was approved by institutional review board (IRB) of research under study STU00073565, Retrospective Study of Molecular Markers in Myeloid Neoplasms. Participate’s consent is available upon request.
: All authors are in agreement for the publication of the study.
: The authors declare that they have no competing interests except for Dr. Jessica K. Altman, who had the following disclosures: prIME Oncology, Speaker, 6/1/2018 Novartis Advisory Board, 6/14/2018 Cancer Expert Now Advisory Board, 6/14/2018 Agios Advisory Board, 12/2/2018 France Foundation Speaker, Data safety and monitoring, 1/10/2019 Glycomimetics, Committee Theradex, Advisory Board, 1/11/2019 AbbVie, Advisory Board, 2/24/2019.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.